MSX1

Chr 4AD

msh homeobox 1

Also known as: ECTD3, HOX7, HYD1, STHAG1

This gene encodes a member of the muscle segment homeobox gene family. The encoded protein functions as a transcriptional repressor during embryogenesis through interactions with components of the core transcription complex and other homeoproteins. It may also have roles in limb-pattern formation, craniofacial development, particularly odontogenesis, and tumor growth inhibition. Mutations in this gene, which was once known as homeobox 7, have been associated with nonsyndromic cleft lip with or without cleft palate 5, Witkop syndrome, Wolf-Hirschom syndrome, and autosomoal dominant hypodontia. [provided by RefSeq, Jul 2008]

OMIMResearchGenerating clinical summary…
LOFmechanismADLOEUF 1.013 OMIM phenotypes
Clinical SummaryMSX1
🧬
Gene-Disease Validity (ClinGen)
tooth agenesis, selective, 1 · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.32) despite low pLI — interpret in context.

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.01LOEUF
pLI 0.165
Z-score 1.57
OE 0.32 (0.131.01)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.28Z-score
OE missense 0.94 (0.821.07)
158 obs / 168.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.32 (0.131.01)
00.351.4
Missense OE?0.94 (0.821.07)
00.61.4
Synonymous OE?1.21
01.21.6
LoF obs/exp: 2 / 6.2Missense obs/exp: 158 / 168.1Syn Z: -1.45
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveMSX1-related cleft lip with or without cleft palateLOFAD

This gene — mechanism propensity

DN
0.6550th %ile
GOF
0.3788th %ile
LOF
0.65top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and dominant-negative). The Badonyi & Marsh model scores dominant-negative highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFprediction above median · 1 literature citation · ClinGen HI: Sufficient evidence for dosage pathogenicity
DNprediction above median · 1 literature citation

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

DNWe propose that the Arg31Pro missense mutation produces the phenotype of FTA via a dominant negative mechanism. Because this homeoprotein is expected to interact with other transcription factors 18·21 and binds DNA 18, Arg31Pro MSXI could functionally inactivate partner proteins as well as perturb 1
LOFA nonsense mutation in MSX1 causes Witkop syndrome2

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

MSX1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →